Number of pages: 120 | Report Format: PDF | Published date: June 10, 2021
Historical Years – 2018 & 2019 | Base Year – 2020 | Forecasted Years – 2021-2031
Report Attribute |
Details |
Revenue forecast in 2031 |
US$ 11.56 billion |
Market size value in 2020 |
US$ 4.48 billion |
Growth Rate |
CAGR of 9.0% from 2021 to 2031 |
Base year for estimation |
2020 |
Forecast period |
2021-2031 |
Segments covered |
Technology, Offering, Application, End User |
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
Market Fundamentals
The polymerase chain reaction (PCR) is a basic molecular technique used for amplifying target sequences from a DNA template in an exponential manner. As significant amount of sample of DNA are necessary for molecular and genetic analysis,
PCR is a fast and inexpensive technique used to "amplify" and copy small segments of DNA. PCR is used in many areas of biology and medicine,
including molecular biology research,
medical diagnostics,
and even some branches of ecology.
[2123123]
Market Dynamics
The global digital PCR (dPCR) and real-time PCR (qPCR) market is mainly driven by rising prevalence of chronic diseases globally,
launch of technologically advanced systems &
kits,
and increasing use of biomarker profiling for disease diagnostics. Furthermore,
several initiatives by government bodies to fast-track the development of PCR is also likely to play a pivotal role in bolstering the market globally. However,
high cost,
false results and shortage of kits &
reagents owing to rising demand for COVID-19 testing are likely to restrain the market growth to a certain extent.
Market Ecosystem
The global digital PCR (dPCR) and real-time PCR (qPCR) market has been analyzed from five perspectives: Technology,
Offering,
Application,
End User,
and Region.
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by Technology
[3420423]
Based on technology,
the market has been segmented into digital PCR (dPCR) and real-time PCR (qPCR). The real-time PCR (qPCR) segment accounted for the largest share in the market. The growth of the segment can be attributed mainly to its benefits such as fast start-up time,
better temperature control,
and real-time measurement. Demand for real-time PCR (qPCR) in fields such as genetic variation analysis,
gene expression analysis,
and genotyping is anticipated to propel the growth of the segment.
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by Offering
Based on offering,
the digital PCR (dPCR) and real-time PCR (qPCR) market has been segmented into instruments,
reagents,
software and services. Reagents segment is expected to be the fastest growing segment in the market in the forecast period. The growth of the segment can be attributed to the easy accessibility of reagents,
their usage across wide range of applications and frequent purchase of reagents unlike instruments.
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by Application
Based on application,
the digital PCR (dPCR) and real-time PCR (qPCR) market has been segmented into clinical application,
research application and forensic application. Clinical application segment dominated the market with the largest share. The growth of the segment can be attributed to rising prevalence of chronic &
acute diseases,
growing adoption of dPCR in hospitals &
diagnostic centers and growing public awareness regarding early &
effective disease diagnosis &
treatment.
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by End User
Based on end user,
the digital PCR (dPCR) and real-time PCR (qPCR) market has been segmented into hospitals,
academic institutes &
research centers,
diagnostic centers and others (clinics, pharmaceutical & biotechnology companies, etc.). Diagnostic centers segment dominated the market owing to the increasing number of diagnostic centers coupled with growing adoption of the dPCR in diagnostic centers and the rise in testing for detection of COVID-19 on an enormous scale.
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by Region
Based on region,
the global Digital PCR (dPCR) and Real-Time PCR (qPCR) market has been segmented into North America,
Europe,
Asia Pacific,
and the Rest of the World (ROW). North America dominated the Digital PCR (dPCR) and Real-Time PCR (qPCR) market,
followed by Asia Pacific. The large share of North America in the global market can largely be attributed to developed healthcare infrastructure,
launch of technologically advanced products,
and presence of large number of clinical laboratories in the region. Moreover,
presence of large number of prominent players and their rising collaboration for launch of advance PCR technology &
reagents are also expected to boost the market.
Competitive Landscape
Some of the prominent players operating in the digital PCR (dPCR) and real-time PCR (qPCR) market includes:-
Strategic Developments
The global digital PCR (dPCR) and real-time PCR (qPCR) market was anticipated to clock US$ 4.48 billion in 2020
The digital PCR (dPCR) and real-time PCR (qPCR) market is projected to reach US$ 11.56 billion by 2031
The global digital PCR (dPCR) and real-time PCR (qPCR) market is mainly driven by rising prevalence of chronic diseases globally, launch of technologically advanced systems & kits, and increasing use of biomarker profiling for disease diagnostics.
Koninklijke Philips N.V, Siemens Healthcare Private Limited, General Electric Company, Hitachi, Ltd, Hologic, Inc, Canon Medical Systems Corporation, Shimadzu Corporation, Fujifilm Holdings Corporation, Carestream Health, Curvebeam
The growth rate of digital PCR (dPCR) and real-time PCR (qPCR) market is CAGR of 9.0% between 2021-2031
North America held the largest market share of the global digital PCR (dPCR) and real-time PCR (qPCR) market in 2020
*Insights on financial performance is subject to availability of information in public domain